4//SEC Filing
Jazz Pharmaceuticals plc 4
Accession 0001232524-14-000029
$JAZZCIK 0001232524operating
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 6:06 PM ET
Size
12.8 KB
Accession
0001232524-14-000029
Insider Transaction Report
Form 4
Tobias Jeffrey K
SVP of Research & Dev and CMO
Transactions
- Exercise/Conversion
Ordinary Shares
2014-03-10$46.83/sh+1,281$59,989→ 49,384 total - Exercise/Conversion
Ordinary Shares
2014-03-10$59.13/sh+1,719$101,644→ 51,103 total - Exercise/Conversion
Nonstatutory Stock Option (right to buy)
2014-03-10−1,281→ 36,421 totalExercise: $46.83Exp: 2022-08-08→ Ordinary Shares (1,281 underlying) - Sale
Ordinary Shares
2014-03-10$152.99/sh−3,000$458,970→ 48,103 total - Exercise/Conversion
Nonstatutory Stock Option (right to buy)
2014-03-10−1,719→ 21,718 totalExercise: $59.13Exp: 2023-03-04→ Ordinary Shares (1,719 underlying)
Footnotes (3)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Following the reported transaction, the remaining ordinary shares subject to this option will vest with respect to 26,889 shares in twenty-one equal monthly installments from April 9, 2014 to December 9, 2015 and with respect to 9,532 shares in eight equal monthly installments from January 9, 2016 to August 9, 2016.
- [F3]Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 4,531 shares and will vest with respect to 4,687 shares in nine equal monthly installments from April 5, 2014 to December 5, 2014 and with respect to 12,500 shares in twenty-four equal monthly installments from January 5, 2015 to December 5, 2016.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001232524
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 6:06 PM ET
- Size
- 12.8 KB